title: Development and application of a high-throughput platform for perfusion-based cell culture processes.
abstract: A high-throughput (HT) cell culture model has been established for the support of perfusion-based cell culture processes operating at high cell densities. To mimic perfusion, the developed platform takes advantage of shake tubes and operates them in a batch-refeed mode with daily medium exchange to supply the cultures with nutrients and remove toxic byproducts. By adjusting the shaking parameters, such as the speed and setting angle, we have adapted the shake tubes to a semi-continuous production of a recombinant enzyme in a perfusion-like mode. We have demonstrated that the developed model can be used to select clones and cell culture media ahead of process optimization studies in bioreactors and confirmed the applicability of shake tubes to a perfusion-like cell culture reaching ∼50E6 viable cells/mL. Furthermore, through regular cell mass removal and periodic medium exchange we have successfully maintained satellite cultures of bench-top perfusion bioreactors, achieving a sustainable cell culture performance at ≥30E6 viable cells/mL and viabilities >80% for over 58 days. The established HT model is a unique and powerful tool that can be used for the development and screening of media formulations, or for testing selected process parameters during both process optimization and manufacturing support campaigns.
authors.affiliation: Genzyme, a Sanofi company, Commercial Cell Culture Development, 45 New York Avenue, Framingham, MA 01701, USA. Electronic address: agata.villiger-oberbek@genzyme.com.
authors.forename: Agata
authors.initials: A
authors.lastname: Villiger-Oberbek
authors.affiliation: Genzyme, a Sanofi company, Commercial Cell Culture Development, 45 New York Avenue, Framingham, MA 01701, USA.
authors.forename: Yang
authors.initials: Y
authors.lastname: Yang
authors.affiliation: Genzyme, a Sanofi company, Commercial Cell Culture Development, 45 New York Avenue, Framingham, MA 01701, USA.
authors.forename: Weichang
authors.initials: W
authors.lastname: Zhou
authors.affiliation: Genzyme, a Sanofi company, Commercial Cell Culture Development, 45 New York Avenue, Framingham, MA 01701, USA.
authors.forename: Jianguo
authors.initials: J
authors.lastname: Yang
mesh_terms: D000818:Animals; D019149:Bioreactors; D016466:CHO Cells; D002452:Cell Count; D018929:Cell Culture Techniques; D002470:Cell Survival; D006224:Cricetinae; D003412:Cricetulus; D008962:Models, Theoretical; D010477:Perfusion
keywords: Batch refeed; High throughput; Perfusion; Satellite culture; Shake tube